Medicine Atlas

How Healing Is Practiced
Sign In
Text size
100%
Theme
Condition

Pituitary stalk interruption syndrome

Endocrine, Nutritional and Metabolic Diseases

Pituitary stalk interruption syndrome, abbreviated PSIS, is a congenital disorder of the pituitary gland defined by a triad of findings: an absent or exceedingly thin pituitary stalk, an ectopic or absent posterior pituitary, and an absent or underdeveloped anterior pituitary. It is a common cause of congenital hypopituitarism and produces a permanent deficiency of growth hormone. Newborns may show low blood sugar and prolonged jaundice, while later childhood features include short stature, seizures, low blood pressure and delayed puberty. It can occur on its own or together with malformations outside the pituitary. The cause is not yet known; rare genetic mutations may explain familial cases, but these account for under five percent. The diagnosis is confirmed by MRI. Treatment begins as soon as the diagnosis is made and consists of hormone replacement, particularly with growth hormone. Prognosis is generally good with prompt treatment, though illness and death are more frequent than in the general population, especially in the first two years of life. About 1,000 cases have been reported, with or without the full triad.

Facts
Classification
Body System
Endocrine System 1
ICD-10 Chapter
IV: Endocrine, Nutritional and Metabolic Diseases 2
Communicable or Non-communicable
Non-Communicable 1
Transmission Route
Non-Transmissible 1
Causative Agent
Causative Agent (category)
Idiopathic / Multifactorial 1
Connections

Treated By

Source Pituitary stalk interruption syndrome (Wikipedia)
Sources
1. Pituitary stalk interruption syndrome (Wikipedia)
  • Presentation
    PSIS is a common cause of congenital hypopituitarism, and causes a permanent growth hormone deficit.
  • Cause
    The cause of the condition is as of yet unknown.
  • Lead
    Pituitary stalk interruption syndrome (PSIS) is a congenital disorder
  • Treated By: Growth hormone therapy, Management
    Treatment should commence as soon as a diagnosis is established to avoid complications, and consists of hormone replacement, particularly with growth hormone.
View the Source
2. Orphadata (Orphanet open data): Orphadata cross-referencing, ORPHAcode 95496
Orphadata (Orphanet open data)External references, ICD-10 mapping E23.6 (chapter IV derived from the code)
Quote, External references, ICD-10 mapping E23.6 (chapter IV derived from the code)
"Reference": "E23.6",
View the Source
Comments (0)
No comments yet. Be the first to share a thought.
Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.